A
Anand Swaroop
Researcher at National Institutes of Health
Publications - 528
Citations - 53580
Anand Swaroop is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Retinitis pigmentosa & Retinal degeneration. The author has an hindex of 89, co-authored 508 publications receiving 43170 citations. Previous affiliations of Anand Swaroop include Vision-Sciences, Inc. & Yale University.
Papers
More filters
Journal ArticleDOI
Genetic Analysis of the Rhodopsin Gene Identifies a Mosaic Dominant Retinitis Pigmentosa Mutation in a Healthy Individual.
Avigail Beryozkin,Gal Levy,Anat Blumenfeld,Segev Meyer,Prasanthi Namburi,Yair Morad,Libe Gradstein,Anand Swaroop,Eyal Banin,Dror Sharon +9 more
TL;DR: This is the first report of the mutation spectrum of a known adRP gene in the Israeli and Palestinian populations, leading to the identification of seven previously reported mutations and one novel mutation.
Journal ArticleDOI
Accelerated Development of Rod Photoreceptors in Retinal Organoids Derived from Human Pluripotent Stem Cells by Supplementation with 9-cis Retinal.
TL;DR: A widely used differentiation protocol is modified by switching all-trans retinoic acid with 9-cis retinal to accelerate photoreceptor differentiation and improve morphogenesis.
Journal ArticleDOI
Characterization of new transcripts enriched in the mouse retina and identification of candidate retinal disease genes
TL;DR: This study demonstrates how bioinformatic analysis can be used to identify novel tissue-specific genes relevant to development and diseases.
Journal ArticleDOI
Association of Rare Predicted Loss-of-Function Variants in Cellular Pathways with Sub-Phenotypes in Age-Related Macular Degeneration.
Alexandra Pietraszkiewicz,Freekje van Asten,Alan Kwong,Rinki Ratnapriya,Gonçalo R. Abecasis,Anand Swaroop,Emily Y. Chew +6 more
TL;DR: Variants in the complement pathway modify the clinical course of AMD and increase the risk of developing specific sub-phenotypes within the population with AMD, and rare pLoF variants are associated with disease progression.